These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 18590333)

  • 1. Ligand-binding pocket shape differences between sphingosine 1-phosphate (S1P) receptors S1P1 and S1P3 determine efficiency of chemical probe identification by ultrahigh-throughput screening.
    Schürer SC; Brown SJ; Gonzalez-Cabrera PJ; Schaeffer MT; Chapman J; Jo E; Chase P; Spicer T; Hodder P; Rosen H
    ACS Chem Biol; 2008 Aug; 3(8):486-98. PubMed ID: 18590333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S1P1-selective in vivo-active agonists from high-throughput screening: off-the-shelf chemical probes of receptor interactions, signaling, and fate.
    Jo E; Sanna MG; Gonzalez-Cabrera PJ; Thangada S; Tigyi G; Osborne DA; Hla T; Parrill AL; Rosen H
    Chem Biol; 2005 Jun; 12(6):703-15. PubMed ID: 15975516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Leu276 of the S1P1 receptor and Phe263 of the S1P3 receptor in interaction with receptor specific agonists by molecular modeling, site-directed mutagenesis, and affinity studies.
    Deng Q; Clemas JA; Chrebet G; Fischer P; Hale JJ; Li Z; Mills SG; Bergstrom J; Mandala S; Mosley R; Parent SA
    Mol Pharmacol; 2007 Mar; 71(3):724-35. PubMed ID: 17170199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and Structure-Activity Relationship (SAR) of potent and selective oxadiazole-based agonists of sphingosine-1-phosphate receptor (S1P
    Liu T; Jin J; Chen Y; Xi Q; Hu J; Jia W; Chen X; Li Y; Wang X; Yin D
    Bioorg Chem; 2019 Feb; 82():41-57. PubMed ID: 30268973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Full pharmacological efficacy of a novel S1P1 agonist that does not require S1P-like headgroup interactions.
    Gonzalez-Cabrera PJ; Jo E; Sanna MG; Brown S; Leaf N; Marsolais D; Schaeffer MT; Chapman J; Cameron M; Guerrero M; Roberts E; Rosen H
    Mol Pharmacol; 2008 Nov; 74(5):1308-18. PubMed ID: 18708635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate.
    Sanna MG; Liao J; Jo E; Alfonso C; Ahn MY; Peterson MS; Webb B; Lefebvre S; Chun J; Gray N; Rosen H
    J Biol Chem; 2004 Apr; 279(14):13839-48. PubMed ID: 14732717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A sphingosine 1-phosphate receptor 2 selective allosteric agonist.
    Satsu H; Schaeffer MT; Guerrero M; Saldana A; Eberhart C; Hodder P; Cayanan C; Schürer S; Bhhatarai B; Roberts E; Rosen H; Brown SJ
    Bioorg Med Chem; 2013 Sep; 21(17):5373-82. PubMed ID: 23849205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly selective and potent agonists of sphingosine-1-phosphate 1 (S1P1) receptor.
    Vachal P; Toth LM; Hale JJ; Yan L; Mills SG; Chrebet GL; Koehane CA; Hajdu R; Milligan JA; Rosenbach MJ; Mandala S
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3684-7. PubMed ID: 16682185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of potent 3,5-diphenyl-1,2,4-oxadiazole sphingosine-1-phosphate-1 (S1P1) receptor agonists with exceptional selectivity against S1P2 and S1P3.
    Li Z; Chen W; Hale JJ; Lynch CL; Mills SG; Hajdu R; Keohane CA; Rosenbach MJ; Milligan JA; Shei GJ; Chrebet G; Parent SA; Bergstrom J; Card D; Forrest M; Quackenbush EJ; Wickham LA; Vargas H; Evans RM; Rosen H; Mandala S
    J Med Chem; 2005 Oct; 48(20):6169-73. PubMed ID: 16190743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand-dependent inhibition of B16 melanoma cell migration and invasion via endogenous S1P2 G protein-coupled receptor. Requirement of inhibition of cellular RAC activity.
    Arikawa K; Takuwa N; Yamaguchi H; Sugimoto N; Kitayama J; Nagawa H; Takehara K; Takuwa Y
    J Biol Chem; 2003 Aug; 278(35):32841-51. PubMed ID: 12810709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery, design and synthesis of a selective S1P(3) receptor allosteric agonist.
    Guerrero M; Poddutoori R; Urbano M; Peng X; Spicer TP; Chase PS; Hodder PS; Schaeffer MT; Brown S; Rosen H; Roberts E
    Bioorg Med Chem Lett; 2013 Dec; 23(23):6346-9. PubMed ID: 24135724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a selective S1P1 receptor agonist, Syl930, as a potential therapeutic agent for autoimmune encephalitis.
    Jin J; Hu J; Zhou W; Wang X; Xiao Q; Xue N; Yin D; Chen X
    Biochem Pharmacol; 2014 Jul; 90(1):50-61. PubMed ID: 24780445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Piperazinyl-oxadiazoles as selective sphingosine-1-phosphate receptor agonists.
    Horan JC; Sanyal S; Choi Y; Hill-Drzewi M; Patnaude L; Anderson S; Fogal S; Mao C; Cook BN; Gueneva-Boucheva K; Fisher MB; Hickey E; Pack E; Bannen LC; Chan DS; Mac MB; Ng SM; Wang Y; Xu W; Modis LK; Lemieux RM
    Bioorg Med Chem Lett; 2014 Oct; 24(20):4807-11. PubMed ID: 25241927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reassessment of the pharmacology of Sphingosine-1-phosphate S1P3 receptor ligands using the DiscoveRx PathHunter™ and Ca2+ release functional assays.
    Riddy DM; Stamp C; Sykes DA; Charlton SJ; Dowling MR
    Br J Pharmacol; 2012 Oct; 167(4):868-80. PubMed ID: 22577868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single amino acid determines preference between phospholipids and reveals length restriction for activation of the S1P4 receptor.
    Holdsworth G; Osborne DA; Pham TT; Fells JI; Hutchinson G; Milligan G; Parrill AL
    BMC Biochem; 2004 Aug; 5():12. PubMed ID: 15298705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacophore-based design of novel oxadiazoles as selective sphingosine-1-phosphate (S1P) receptor agonists with in vivo efficacy.
    Quattropani A; Sauer WH; Crosignani S; Dorbais J; Gerber P; Gonzalez J; Marin D; Muzerelle M; Beltran F; Nichols A; Georgi K; Schneider M; Vitte PA; Eligert V; Novo-Perez L; Hantson J; Nock S; Carboni S; de Souza AL; Arrighi JF; Boschert U; Bombrun A
    ChemMedChem; 2015 Apr; 10(4):688-714. PubMed ID: 25735812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of endothelial nitric oxide synthase activation in endothelial cells by S1P1 and S1P3.
    Tölle M; Klöckl L; Wiedon A; Zidek W; van der Giet M; Schuchardt M
    Biochem Biophys Res Commun; 2016 Aug; 476(4):627-634. PubMed ID: 27282481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the hydrophobic ligand binding pocket of the S1P1 receptor.
    Fujiwara Y; Osborne DA; Walker MD; Wang DA; Bautista DA; Liliom K; Van Brocklyn JR; Parrill AL; Tigyi G
    J Biol Chem; 2007 Jan; 282(4):2374-85. PubMed ID: 17114791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of the first sphingosine 1-phosphate receptor.
    Parrill AL; Lima S; Spiegel S
    Sci Signal; 2012 May; 5(225):pe23. PubMed ID: 22623751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel selective allosteric and bitopic ligands for the S1P(3) receptor.
    Jo E; Bhhatarai B; Repetto E; Guerrero M; Riley S; Brown SJ; Kohno Y; Roberts E; Schürer SC; Rosen H
    ACS Chem Biol; 2012 Dec; 7(12):1975-83. PubMed ID: 22971058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.